Condition

SARS-CoV 2 (2)

Anxiety (1)

COVID-19 (1)

Corona Virus Infection (1)

Depression (1)

Family Members (1)

Post Intensive Care Unit Syndrome (1)

Post Traumatic Stress Disorder (1)

Respiratory Failure (1)

Overall Status

Completed (1)

Terminated (1)

Phase

phase 2 (1)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID) (1)

University of Colorado, Denver (1)

Collaborator

Brigham and Women's Hospital (1)

Columbia University (1)

Evergreen Hospital (1)

Penn State University (1)

South Shore Hospital (1)

Teva Pharmaceutical Industries, Ltd. (1)

Tulane University (1)

University of Vermont (1)

University of Washington (1)

Intervention

azithromycin (azithro) (1)

hydroxychloroquine (hcq) (1)

placebo for azithromycin (1)

placebo for hydroxychloroquine (1)

Study Documents

Intervention Type

drug (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (1)

Observational (1)

SARS-CoV 2

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

COVID-19, SARS-CoV 2 Trial in United States (Hydroxychloroquine (HCQ), Azithromycin (Azithro), Placebo for Hydroxychloroquine)

Terminated

Has Results

COVID-19
SARS-CoV 2

Hydroxychloroquine (HCQ)
+3 more

Birmingham, Alabama
+10 more

Nov 12, 2021

Disorders in Family Members of COVID-19 Patients Admitted to ICU

Completed

Respiratory Failure
+7 more

Aurora, Colorado
+8 more

Jun 18, 2021